EHR-Based Interventions for Breast and Ovarian Cancer Genetic Testing
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this sequential study design is to increase genetic testing in those meeting national clinical guidelines. The main question it aims to answer is: which intervention is most effective in uptake of genetic testing for the target population? Participants will receive genetic testing and counseling that may initiate life-saving screenings.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
Is EHR-based intervention for genetic testing safe for humans?
The research does not provide specific safety data for EHR-based interventions for genetic testing, but it focuses on improving documentation and referral processes in electronic health records, which are generally safe as they involve administrative and informational improvements rather than direct medical treatments.12345
How does the treatment Sequential EHR Communications differ from other treatments for breast and ovarian cancer genetic testing?
Sequential EHR Communications is unique because it leverages electronic health records (EHR) to improve the referral process for genetic testing, ensuring that more patients who meet the criteria for genetic risk assessment are identified and referred. This approach addresses the underutilization of genetic testing by systematically capturing and using risk factor information already present in EHRs, which is not a standard practice in traditional treatments.13456
What data supports the effectiveness of the treatment Sequential EHR Communications for breast and ovarian cancer genetic testing?
Research shows that using electronic health records (EHRs) to streamline referrals for genetic testing in ovarian cancer patients can improve the rate of referrals and testing completion. This suggests that similar EHR-based interventions could be effective in increasing genetic testing for breast and ovarian cancer.15789
Are You a Good Fit for This Trial?
This trial is for people with a family history of breast or ovarian cancer, especially if diagnosed before age 50, and those with specific types of these cancers diagnosed over two years ago. It's not open to anyone who has already had genetic counseling or testing.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive sequential EHR-based interventions to increase genetic testing uptake, including direct messages, text messages, and provider nudges
Follow-up
Participants are monitored for the completion of genetic counseling appointments and response to interventions
What Are the Treatments Tested in This Trial?
Interventions
- Sequential EHR Communications
Find a Clinic Near You
Who Is Running the Clinical Trial?
Abramson Cancer Center of the University of Pennsylvania
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Lead Sponsor